Dr. Niman, thanks for this document. These are some excerpts that I found interesting (and could comprehend!) Is this the correct listing for the Egypt-2 sequences they used for this study?
Quote:
H5N1 (Egypt-2) (Figure 2b): A/Egypt/0636-NAMRU3/2007 [EF382359];
A/Egypt/14725-NAMRU3/2006 [EF200513]; A/duck/Egypt/2253-3/2006 [DQ862002];
A/duck/Egypt/1301-NAMRU3/2007 [EF441281]; A/chicken/Egypt/1081NAMRU3/
2006 [EF441279]; A/chicken/Egypt/1080-NAMRU3/2006 [EF441278];
A/chicken/Egypt/1079-NAMRU3/2007 [EF441277]; A/Egypt/14724-NAMRU3/2006
[EF200512]; A/chicken/Egypt/1889N3-SM26/2007 [EF469653];
A/chicken/Egypt/1892N3-HK49/2007 [EF469660]; A/duck/Egypt/1888N3-SM25/2007
[EF469657]; A/Egypt/1394-NAMRU3/2007 [EF535817]; A/Egypt/1604-NAMRU3/2007
[EF535818]; A/Egypt/1731-NAMRU3/2007 [EF535819]; A/Egypt/2621-NAMRU3/2007
[EF535826]; A/ goose/Egypt/R4/2007 [EU183330]; A/chicken/Egypt/F6/2007
[EU183326]; A/chicken/Egypt/R6/2007 [EU183332]; A/duck/Egypt/R5/2007
[EU183331]; A/chicken/Egypt/R3/2007 [EU183329] ; A/chicken/Egypt/R2/2007
[EU183328]; A/Egypt/2629-NAMRU3/2007 [EU095025]; A/Egypt/2631NAMRU3/
2007 [EU095027]; A/Egypt/2947-NAMRU3/2006 [EF042617];
A/chicken/Egypt/9385NAMRU3-CLEVB125/2007 [EU371910]; A/chicken/Egypt/
9390NAMRU3-CLEVB157/2007 [EU371915]; A/chicken/Egypt/9392NAMRU3CLEVB167/
2007 [EU371917]; A/chicken/Egypt/ 9387NAMRU3-CLEVB148/2007
[EU371912]; A/chicken/Egypt/3051NAMRU3-CLEVB78/2007 [EU371905];
A/chicken/Egypt/9386NAMRU3-CLEVB/136/2007 [EU371911]; A/chicken/Egypt/
9391NAMRU3-CLEVB158/2007 [EU371916];
|
Excerpts:
Despite its low infectivity for humans, there has been evidence in Egypt of several
clusters of human-to-human transmission with very high mortality rate
-snip-
Figure 4 shows the IS spectra of peptide VIN1 and of the domains identified by
consensus IS of H1N1, H3N2, H5N1 and H7N7 viruses (Table 2) and the position of
these domains in the molecule. As can be seen, the receptor targeting site of H5N1 virus
from the group Egypt-1 (A/Egypt/0636-NAMRU3/2007)
is closer to the receptor binding
site than in the other viruses of Figure 4. It may be speculated that this may affect the
efficacy of the virus/receptor interaction.
Finally, we compared informational properties of H1N1 pandemic strains from 1918
from GenBank and seasonal H1N1 strains. The consensus IS of these pandemic isolates
(Figure 3) is characterized by a dominant peak of the frequency F(0.258) which is different from the frequency F(0.236) characteristic of other seasonal flu H1N1 isolates
(Figure 1d).
Table 2 shows the domain corresponding to the frequency F(0.258). In the
model of A/South Carolina/1/18 (Figure 4i) the position of this domain does not overlap
with the corresponding domain of other seasonal H1N1 strains, but overlaps with the
corresponding domain of Egypt-2 H5N1 viruses.
-snip-
H5N1 already replicates efficiently in humans, and cause case fatality rates that are ten
times higher than those seen in the 1918 pandemic. Thus, an infectivity of H5N1 similar
to seasonal flu would cause a catastrophic pandemic. The main obstacle for this worst
case scenario is poor human-to-human transmission of H5N1 viruses, which is attributed
to the paucity of sialic acid a2,3 receptor in the epithelium of the human upper respiratory
tract, and the inability of the virus to replicate efficiently at this site. Interestingly, the
ISM approach identifies important differences between H5N1 viruses from Egypt. Some
have the characteristics of most H5N1 strains whereas about one third of the viruses
display characteristics that are also found in human H1N1 seasonal virus. Interestingly
the proportion of the latter viruses has increased from 25 to about 50: between 2006 and
2007.
Similarly the results of H5N1 strains from Egypt (Figure 2) may be indicative of a
possible viral evolution towards receptor usage similar to that of H1N1 viruses, which
efficiently replicate in the upper respiratory tract. The protein domain, which seems to be involved in this subtle change, corresponds to amino acid domain 99-132 (Figure 4g).
However, the role of this domain for enhanced infectivity in humans remains elusive.
Interestingly the corresponding domain of Spanish flu viruses
and Egypt-2 H5N1 viruses
are much closer to the receptor binding site of HA1 than in all other H1N1 and H5N1
viruses (Figures 4e-4i and Table 2). This closer proximity may indicate more efficient
virus/receptor interactions in these influenza viruses.*
Finally, we will discuss some of recently reported experimental results which point out
functional and immunological role of H5 HA domain encompassing peptide VIN1. In
order to identify mutations which increase the recognition of H5 HA by SA•2,6Gal
human type receptor, Su and co-workers compared HA from
A/chicken/Ffujian/1042/2005 as wild type with isolates identified in both poultry and
humans in mainland China, Hong Kong, Thailand, and Vietnam during outbreaks
between 1996 and 2005 [29]. Unexpectedly, this analysis revealed six amino acid
substitutions (K35R, D45N, D94N, K35R/D45N, K35R/45N/D94N, A247T) outside the
receptor-binding domain of HA, which could enhance interaction between H5 HA and
human-type SA•2,6Gal receptor. As can be seen, three of these mutations encompass
mutation D45N which is located within peptide VIN1 and two other mutations (K35R
and D94N) are located in its vicinity. It is the first report that naturally occurring
mutations in region of H5 HA which encompasses peptide VIN1 play an important role
in virus transmission from avian to human. It is of note that Egyptian strains contain all
of these mutations, except mutation in position K35. These results point out need for
future testing of evolution of Egyptian strains using hemiadsorption assays for HA receptor-binding activity in order to identify possible new mutations in this domain of
HA which could increase affinity of H5N1 viruses to human-type receptor.
-snip-
It is of note that recent Egypt group-2 strains are characterized by N43, in
contrast to Egypt group-1 strains which contain D43. It means that the 4G6 MAb can not
be used for detection and neutralization of H5N1 viruses belonging to the Egypt group-2.
-snip-
(iv) at least in Egypt H5N1 viruses
have acquired features that may adapt them for H1N1-like receptor usage possibly
allowing more efficient human-to-human transmission.
-snip-
Figures:
Figure 1 -ISM analysis of HA1 proteins of H5 influenza viruses.
(a) Consensus IS of HA1 of all H5N1 sequences in GenBank (n=1407); (b) IS of H5N3
(A/swan/Hokkaido/51/96), the progenitor of H5N1, and (c) of the first isolated H5N1
virus (A/Goose/ Guangdong/1/96); (d) consensus IS of H1N1 (n=30), (e) of H3N2 (n=30)
and (f) of H7N7 (n=30).
Figure 2 -The ISM analysis of HA1 proteins of H5N1 viruses isolated in Egypt in
2006/2007.
(a) consensus IS of Egypt-1 and (b) of Egypt-2 strains, (c) IS of a representative Egypt-1
(A/teal/Egypt/9885-NAMRU3/2005) and (d) Egypt-2 virus (A/chicken/Egypt/R6/2007).
Figure 3 -Consensus IS of HA1 from three Spanish flu H1N1 viruses.
Figure 4 -Overview of H5 HA trimer (PDB: 2ibx) and details of the VIN1 region.
Domains of H1N1, H3N2, H5N1, H7N1 and Spanish flu identified by consensus IS
(Table 2) and their position in the 3D structure of HA1 and the IS of the peptide
sequence. (e) A/New York/383/2004 (H3N2); (f) A/equine/Prague/56 (H7N7); (g)
A/Egypt/0636-NAMRU3/2007(H5N1); (h) A/New Caledonia/20/99 (H1N1);
(i) A/South
Carolina/1/18 (H1N1).